Stifel Nicolaus Issues Positive Forecast for Lam Research (NASDAQ:LRCX) Stock Price

Lam Research (NASDAQ:LRCX) had its price target lifted by Stifel Nicolaus from $250.00 to $280.00 in a report published on Thursday, MarketBeat.com reports. Stifel Nicolaus currently has a buy rating on the semiconductor company’s stock.

Other analysts have also issued reports about the stock. Berenberg Bank raised their price target on shares of Lam Research from $122.00 to $165.00 and gave the stock a “buy” rating in a research report on Thursday, October 23rd. Deutsche Bank Aktiengesellschaft lifted their target price on Lam Research from $260.00 to $290.00 and gave the stock a “buy” rating in a research report on Thursday. Barclays set a $250.00 price target on Lam Research in a research note on Thursday. BNP Paribas Exane raised their price objective on Lam Research from $80.00 to $140.00 and gave the stock a “neutral” rating in a research report on Thursday, October 23rd. Finally, Mizuho set a $265.00 price objective on Lam Research in a research report on Wednesday. One investment analyst has rated the stock with a Strong Buy rating, twenty-seven have given a Buy rating and seven have assigned a Hold rating to the company’s stock. According to MarketBeat, Lam Research presently has an average rating of “Moderate Buy” and a consensus price target of $234.55.

Lam Research Price Performance

NASDAQ LRCX opened at $248.17 on Thursday. The stock has a market capitalization of $311.71 billion, a PE ratio of 50.85, a P/E/G ratio of 3.03 and a beta of 1.77. The stock has a 50-day simple moving average of $185.48 and a 200 day simple moving average of $145.09. The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.60 and a current ratio of 2.21. Lam Research has a twelve month low of $56.32 and a twelve month high of $251.38.

Lam Research (NASDAQ:LRCX) last issued its quarterly earnings results on Wednesday, January 28th. The semiconductor company reported $1.27 EPS for the quarter, topping the consensus estimate of $1.17 by $0.10. Lam Research had a return on equity of 63.28% and a net margin of 30.22%.The company had revenue of $5.34 billion for the quarter, compared to the consensus estimate of $5.23 billion. During the same period in the previous year, the business posted $0.91 EPS. The company’s revenue for the quarter was up 22.1% on a year-over-year basis. Lam Research has set its Q3 2026 guidance at 1.250-1.450 EPS. Research analysts anticipate that Lam Research will post 3.71 EPS for the current year.

Lam Research Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Wednesday, January 7th. Shareholders of record on Wednesday, December 3rd were given a $0.26 dividend. This represents a $1.04 dividend on an annualized basis and a yield of 0.4%. The ex-dividend date was Wednesday, December 3rd. Lam Research’s dividend payout ratio is 21.31%.

Insider Buying and Selling at Lam Research

In related news, CFO Douglas R. Bettinger sold 40,080 shares of the stock in a transaction dated Friday, November 14th. The shares were sold at an average price of $150.60, for a total transaction of $6,036,048.00. Following the completion of the sale, the chief financial officer owned 987,237 shares in the company, valued at $148,677,892.20. This trade represents a 3.90% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, Director Bethany Mayer sold 1,298 shares of Lam Research stock in a transaction dated Monday, November 3rd. The shares were sold at an average price of $159.99, for a total transaction of $207,667.02. Following the transaction, the director directly owned 1,652 shares of the company’s stock, valued at $264,303.48. This represents a 44.00% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 41,408 shares of company stock valued at $6,248,501 over the last quarter. Corporate insiders own 0.31% of the company’s stock.

Institutional Inflows and Outflows

A number of institutional investors have recently modified their holdings of LRCX. PMV Capital Advisers LLC acquired a new stake in Lam Research in the fourth quarter worth about $25,000. IMG Wealth Management Inc. bought a new position in shares of Lam Research in the 2nd quarter valued at about $26,000. Stance Capital LLC acquired a new stake in shares of Lam Research during the 3rd quarter worth approximately $26,000. Howard Hughes Medical Institute acquired a new stake in shares of Lam Research during the 2nd quarter worth approximately $27,000. Finally, Triumph Capital Management bought a new stake in shares of Lam Research during the third quarter worth approximately $27,000. Institutional investors own 84.61% of the company’s stock.

Key Lam Research News

Here are the key news stories impacting Lam Research this week:

• Positive Sentiment: Q2 results beat expectations — EPS $1.27 vs. $1.17 est., revenue $5.34B (+22% Y/Y); company issued stronger-than-expected Q3 revenue and EPS guidance. PR News Release
• Positive Sentiment: Management pointed to robust AI-driven demand and higher bookings, prompting commentary that the quarter was “extraordinarily bullish” from some outlets — supportive for near-term revenue visibility. Barron’s: Why Earnings Were ‘Extraordinarily Bullish’
• Positive Sentiment: Large wave of analyst price-target increases and upgrades after results (JPMorgan, Citi, UBS, Wells Fargo, Deutsche Bank, Stifel, Needham, TD Cowen, Summit upgrades), reflecting consensus optimism on demand and execution. Benzinga roundup of analyst boosts
• Positive Sentiment: High-profile bull commentary (Jim Cramer) highlighting structural shortage/strong demand for Lam’s tools — supports momentum and retail/institutional interest. InsiderMonkey: Jim Cramer on Lam Research
• Neutral Sentiment: Deep-dive coverage and investor takeaways highlight expansion plans and capex exposure as Lam scales production to meet wafer-equipment demand — positive for growth but capex cadence can fluctuate results. Yahoo Finance: LRCX Q4 Deep Dive
• Negative Sentiment: Valuation questions: coverage notes and some analysts caution about elevated multiples after the rally; Forbes flags the stock’s history of sharp pullbacks — risk of volatility despite strong results. Forbes: Record Highs May Face Reality Check
• Negative Sentiment: One analyst (Morgan Stanley) keeps an equal-weight rating with a lower target vs. several bullish upgrades — a reminder not all houses are uniformly bullish and limiting near-term upside for cautious funds. Benzinga: Morgan Stanley note

Lam Research Company Profile

Lam Research Corporation (NASDAQ: LRCX) is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.

Lam’s product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.